GTR 114383707
Bids Are Invited For Registration Of Prices For Future And Eventual Acquisition Of Medicines And Related Products For Injectable Use.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
114383707
Tendering Authority
Subscribe to view
Tender No
44/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Registration Of Prices For Future And Eventual Acquisition Of Medicines And Related Products For Injectable Use.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
25-06-2026
Closed
Work Detail
Medroxyprogesterone Acetate 25Mg + Estradiol Cypionate 5Mg - Injectable Suspension - 0.5Ml, Zoledronic Acid 0.05Mg/Ml - Injectable Solution - 100Ml (Vial/Ampule - As Per Notice), Atropine 0.5Mg/Ml - Injectable Solution - 1Ml, Trypan Blue 0.1% (1Mg/Ml) - Intraocular Use - 1Ml, Bupivacaine 0.5% + Glucose 8% (Sterile Secondary Packaging) - Injectable Solution - 4Ml, Certolizumab 200Mg/Ml - Injectable Solution - 1Ml (Filled Syringe - As Per Notice), Cyclophosphamide 1000Mg - Lyophilized Powder For Injectable Solution, Thiamine Hydrochloride 100Mg + Pyridoxine Hydrochloride 100Mg + Cyanocobalamin 5000Mcg + Dexamethasone Phosphate 4Mg - Injectable Solution, Etanercept 50Mg/Ml - Injectable Solution - 1Ml (Filled Syringe - As Per Notice), Etilephrine 10Mg/Ml - Injectable Solution - 1Ml, Fluorescein Sodium 20% - Injectable Solution - 5Ml (Ampule/Ampule Vial - As Per Notice), Golimumab 50Mg - Injectable Solution - 0.5Ml (Prefilled Syringe - As Per Notice), Heparin Sodium 5000Ui/0.25Ml - Injectable Solution - 0. 25Ml, Insulin Aspart 100U/Ml - Injectable Solution - 10Ml, Insulin Aspart 100U/Ml - Injectable Solution - 3Ml (Carpule - As Per Notice), Insulin Aspart 100U/Ml - Injectable Solution - 3Ml (Filled Application System - As Per Notice), Insulin Degludec 100 U/Ml + Liraglutide 3.6Mg/Ml – 3Ml (Filled Application System - According To Notice), Insulin Degludec 100U/Ml - Injectable Solution - 3Ml (Filled Application System - According To Notice), Insulin Glargine 100Ui/Ml - Injectable Solution - 3Ml (Carpule - According To Notice), Insulin Glulisine 100Ui/Ml - Injectable Solution - 3Ml (Completed Application System - According To Notice), Human Insulin Nph 100Ui/Ml - Injectable Suspension - 10Ml, Regular Human Insulin 100Ui/Ml - Injectable Solution - 10Ml, Leuprorelin 3, 75Mg (Prolonged Release) - Powder For Injectable Solution + Diluent + Needle, Leuprorelin 7.5 Mg (Prolonged Release) - Powder For Injectable Solution + Diluent + Needle, Lidocaine 10Mg/Ml With Vasoconstrictor (Epinephrine) 1:200,000 - Injectable Solution - 20Ml, Lidocaine 2% With Vasoconstrictor - Injectable Solution - 1.8Ml (Carpule - As Per Notice), Lidocaine 2% Without Vasoconstrictor - Injectable Solution - 1, Lidocaine 50Mg/Ml + Glucose 75Mg/Ml - Injectable Solution - 2Ml, Metaraminol 10Mg/Ml - Injectable Solution - 1Ml, Nitroglycerin 5Mg/Ml - Injectable Solution - 5Ml, Silicone Oil 5000 Cps - Intraocular Use - 8Ml, Paricalcitol 5Mcg/Ml - Injectable Solution - 1Ml, Protamine 10Mg/Ml - Injectable Solution - 5Ml, Semaglutide 0.68Mg/Ml - Injectable Solution - 1, 5Ml (Filled Application System - As Per Notice), Semaglutide 1, 34Mg/Ml - Injectable Solution - 1, 34Mg/Ml - Injectable Solution - 3Ml (Filled Application System - As Per Notice), Semaglutide 2, 27Mg/Ml - Injectable Solution - 3Ml (Filled Application System - As Per Notice), Semaglutide 3, 2Mg/Ml - Injectable Solution - 3Ml (Completed Application System - According To Notice), Tocilizumab 20Mg/Ml - Injectable Solution - 4Ml, Botulinum Toxin 500 U - Lyophilized Powder For Injectable Solution, Triamcinolone 40Mg/Ml - Ophthalmic Use - No Preservative - 1Ml
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
8646ca79-1745-4eed-8a60-d756f60a7d03.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.